DIN 02491788 — CALQUENCE 100 MG
CALQUENCE is a capsule of Acalabrutinib marketed by ASTRAZENECA CANADA INC. The full Acalabrutinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02491788
- Brand name
- CALQUENCE
- Active ingredient
- Acalabrutinib
- Strength
- 100 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- ASTRAZENECA CANADA INC
- Health Canada status
- DORMANT
- Drug class
- Bruton's tyrosine kinase (BTK) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Acalabrutinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02535696 | CALQUENCE | 100 MG | TABLET | ASTRAZENECA CANADA INC | MARKETED |